Lindfors NC - Search Results

1

Increase in VEGF secretion from human fibroblast cells by bioactive glass S53P4 to stimulate angiogenesis in bone.

Detsch R, Stoor P, Grünewald A, Roether JA, Lindfors NC, Boccaccini AR. Detsch R, et al. Among authors: lindfors nc. J Biomed Mater Res A. 2014 Nov;102(11):4055-61. doi: 10.1002/jbm.a.35069. Epub 2014 Jan 17. J Biomed Mater Res A. 2014. PMID: 24357515

2

Detecting Distal Radius Fractures Using a Segmentation-Based Deep Learning Model.

Anttila TT, Karjalainen TV, Mäkelä TO, Waris EM, Lindfors NC, Leminen MM, Ryhänen JO. Anttila TT, et al. Among authors: lindfors nc. J Digit Imaging. 2023 Apr;36(2):679-687. doi: 10.1007/s10278-022-00741-5. Epub 2022 Dec 21. J Digit Imaging. 2023. PMID: 36542269 Free PMC article.

3

Bone morphogenic protein expression and bone formation are induced by bioactive glass S53P4 scaffolds in vivo.

Björkenheim R, Strömberg G, Ainola M, Uppstu P, Aalto-Setälä L, Hupa L, Pajarinen J, Lindfors NC. Björkenheim R, et al. Among authors: lindfors nc. J Biomed Mater Res B Appl Biomater. 2019 Apr;107(3):847-857. doi: 10.1002/jbm.b.34181. Epub 2018 Sep 8. J Biomed Mater Res B Appl Biomater. 2019. PMID: 30194906

4

Bioactive glasses induce chemiluminescence by human polymorphonuclear leukocytes.

Lindfors NC, Klockars M, Ylänen H. Lindfors NC, et al. J Biomed Mater Res. 1999 Oct;47(1):91-4. doi: 10.1002/(sici)1097-4636(199910)47:1<91::aid-jbm13>3.0.co;2-f. J Biomed Mater Res. 1999. PMID: 10400886

5

Immunoglobulin enhances the bioactive-glass-induced chemiluminescence response of human polymorphonuclear leukocytes.

Lindfors NC, Klockars M. Lindfors NC, et al. J Biomed Mater Res. 2001 Jun 15;55(4):613-7. doi: 10.1002/1097-4636(20010615)55:4<613::aid-jbm1055>3.0.co;2-h. J Biomed Mater Res. 2001. PMID: 11288090

6

Bioactive glass as bone-graft substitute for posterior spinal fusion in rabbit.

Lindfors NC, Tallroth K, Aho AJ. Lindfors NC, et al. J Biomed Mater Res. 2002;63(2):237-44. doi: 10.1002/jbm.10177. J Biomed Mater Res. 2002. PMID: 11870659

7

Long-term evaluation of blood silicon and ostecalcin in operatively treated patients with benign bone tumors using bioactive glass and autogenous bone.

Lindfors NC, Heikkilä JT, Aho AJ. Lindfors NC, et al. J Biomed Mater Res B Appl Biomater. 2008 Oct;87(1):73-6. doi: 10.1002/jbm.b.31070. J Biomed Mater Res B Appl Biomater. 2008. PMID: 18433009 Clinical Trial.

8

Bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors.

Lindfors NC, Heikkilä JT, Koski I, Mattila K, Aho AJ. Lindfors NC, et al. J Biomed Mater Res B Appl Biomater. 2009 Jul;90(1):131-6. doi: 10.1002/jbm.b.31263. J Biomed Mater Res B Appl Biomater. 2009. PMID: 18988277 Clinical Trial.

9

A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors.

Lindfors NC, Koski I, Heikkilä JT, Mattila K, Aho AJ. Lindfors NC, et al. J Biomed Mater Res B Appl Biomater. 2010 Jul;94(1):157-64. doi: 10.1002/jbm.b.31636. J Biomed Mater Res B Appl Biomater. 2010. PMID: 20524190 Clinical Trial.

10

Antibacterial Bioactive Glass, S53P4, for Chronic Bone Infections - A Multinational Study.

Lindfors N, Geurts J, Drago L, Arts JJ, Juutilainen V, Hyvönen P, Suda AJ, Domenico A, Artiaco S, Alizadeh C, Brychcy A, Bialecki J, Romanò CL. Lindfors N, et al. Adv Exp Med Biol. 2017;971:81-92. doi: 10.1007/5584_2016_156. Adv Exp Med Biol. 2017. PMID: 28050878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters